Stephen J. Freedland
Tracked across 1 events · 6 articles · First seen Aug 10, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
A real-world study published online in CANCER, a peer-reviewed journal of the American Cancer Society, analyzed data from 4,890 patients with metastatic hormone-sensitive prostate cancer treated through the United States — Veterans Health Administration between…
Impact: Stephen J. Freedland is the corresponding author and a key figure in the study, providing clinical interpretation and advocating for the PSA target.
Aug 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Stephen J. Freedland live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard